Researchers are excited about the medication , a novel dual compound showing promising outcomes in early trials for size reduction . It acts by modulating two systems: GLP-1 and GIP, which , when https://adrianaxxts457879.blogchaat.com/41055744/this-new-hope-for-size-reduction